TFS Capital’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-61,010
Closed -$946K 85
2017
Q2
$946K Buy
61,010
+46,703
+326% +$724K 0.37% 50
2017
Q1
$247K Buy
+14,307
New +$247K 0.08% 419